INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 103 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $302,757 | -53.4% | 545,508 | 0.0% | 0.01% | -55.6% |
Q3 2022 | $649,000 | +88.1% | 545,508 | 0.0% | 0.03% | +107.7% |
Q2 2022 | $345,000 | -44.5% | 545,508 | 0.0% | 0.01% | -31.6% |
Q1 2022 | $622,000 | -49.3% | 545,508 | 0.0% | 0.02% | -44.1% |
Q4 2021 | $1,227,000 | -34.2% | 545,508 | 0.0% | 0.03% | -35.8% |
Q3 2021 | $1,866,000 | +18.4% | 545,508 | +3.5% | 0.05% | +47.2% |
Q2 2021 | $1,576,000 | -7.5% | 527,101 | 0.0% | 0.04% | -5.3% |
Q1 2021 | $1,703,000 | +6.3% | 527,101 | -30.2% | 0.04% | +2.7% |
Q4 2020 | $1,602,000 | +48.7% | 755,593 | -17.9% | 0.04% | +37.0% |
Q3 2020 | $1,077,000 | +29.4% | 920,294 | 0.0% | 0.03% | +42.1% |
Q2 2020 | $832,000 | +7.9% | 920,294 | 0.0% | 0.02% | 0.0% |
Q1 2020 | $771,000 | -29.4% | 920,294 | -19.1% | 0.02% | -13.6% |
Q4 2019 | $1,092,000 | -6.8% | 1,137,647 | 0.0% | 0.02% | -15.4% |
Q3 2019 | $1,172,000 | -42.8% | 1,137,647 | 0.0% | 0.03% | -45.8% |
Q2 2019 | $2,048,000 | -4.3% | 1,137,647 | 0.0% | 0.05% | -4.0% |
Q1 2019 | $2,139,000 | +59.4% | 1,137,647 | 0.0% | 0.05% | +11.1% |
Q4 2018 | $1,342,000 | -50.0% | 1,137,647 | +14.8% | 0.04% | -40.8% |
Q3 2018 | $2,685,000 | +24.4% | 990,748 | -12.4% | 0.08% | +49.0% |
Q2 2018 | $2,159,000 | -20.9% | 1,130,432 | -13.0% | 0.05% | -32.9% |
Q1 2018 | $2,728,000 | +4.5% | 1,299,232 | +1.0% | 0.08% | +10.1% |
Q4 2017 | $2,610,000 | +39.1% | 1,286,032 | -8.9% | 0.07% | +46.8% |
Q3 2017 | $1,877,000 | +47.6% | 1,411,832 | +74.3% | 0.05% | +34.3% |
Q2 2017 | $1,272,000 | -51.4% | 810,232 | 0.0% | 0.04% | -52.1% |
Q1 2017 | $2,617,000 | +289.4% | 810,232 | +62.6% | 0.07% | +265.0% |
Q4 2016 | $672,000 | -13.5% | 498,232 | 0.0% | 0.02% | +11.1% |
Q3 2016 | $777,000 | +17.4% | 498,232 | 0.0% | 0.02% | +12.5% |
Q2 2016 | $662,000 | -39.3% | 498,232 | +140.8% | 0.02% | -33.3% |
Q1 2016 | $1,090,000 | -5.5% | 206,932 | +40.8% | 0.02% | -4.0% |
Q4 2015 | $1,153,000 | +26.4% | 146,932 | +36.1% | 0.02% | 0.0% |
Q3 2015 | $912,000 | -22.8% | 107,932 | 0.0% | 0.02% | +4.2% |
Q2 2015 | $1,181,000 | -21.7% | 107,932 | 0.0% | 0.02% | -20.0% |
Q1 2015 | $1,508,000 | -17.2% | 107,932 | 0.0% | 0.03% | -14.3% |
Q4 2014 | $1,822,000 | +25.8% | 107,932 | 0.0% | 0.04% | +20.7% |
Q3 2014 | $1,448,000 | +38.8% | 107,932 | +31.7% | 0.03% | +61.1% |
Q2 2014 | $1,043,000 | +99.8% | 81,932 | +86.5% | 0.02% | +100.0% |
Q1 2014 | $522,000 | -13.9% | 43,932 | 0.0% | 0.01% | -10.0% |
Q4 2013 | $606,000 | -20.8% | 43,932 | 0.0% | 0.01% | -28.6% |
Q3 2013 | $765,000 | +126.3% | 43,932 | +109.9% | 0.01% | +133.3% |
Q2 2013 | $338,000 | – | 20,932 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 7,866,108 | $25,408,000 | 4.32% |
Nine Chapters Capital Management LLC | 91,500 | $296,000 | 0.40% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,969,225 | $6,361,000 | 0.24% |
Orbimed Advisors | 3,250,300 | $10,498,000 | 0.12% |
PINNACLE ASSOCIATES LTD | 1,306,679 | $4,221,000 | 0.08% |
PLATINUM INVESTMENT MANAGEMENT LTD | 810,232 | $2,617,000 | 0.07% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 270,417 | $873,000 | 0.06% |
Rock Springs Capital Management LP | 270,000 | $872,000 | 0.05% |
ALGERT GLOBAL LLC | 39,876 | $129,000 | 0.04% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 391,671 | $1,265,000 | 0.03% |